Cure Childhood Cancer

Scientific Advisory Council

If the key to finding the cure for childhood cancer is research, how do we decide which research projects to fund? We look to our 9067-0122Scientific Advisory Council to guide our choices.

Comprised of doctors, scientists and experts, the council studies the status of current research funded by CURE, as well as that funded since 2006. They assess the outcomes and identify successful projects to make funding recommendations that align with CURE’s research goals.

Currently, our focus is on projects aimed at the 20% of children diagnosed with cancer who are not surviving today’s methods of treatment. With that in mind, in fiscal year 2014-2015, we will fund research involving the highest risk pediatric cancers that fall into one of the following categories:

1. Innovative clinical therapy and transplantation

2. Mechanism of drug resistance and drug discovery

3. Study of novel tumor biomarkers for diagnostic, prognostic, therapeutic and
vaccine development potential

4. Genetics and/or Genomics as related to cancer development, resistance,
mechanism

We’re also interested in projects focused on survivorship that evaluate short-term and long-term consequences of cancer and anti-cancer therapy in patients who are cured, in order to improve the quality of life during and after treatment.

The CURE Scientific Advisory Council includes:

  • Kevin L. Karem, PhD: Scientist – Council Chair
  • Terri Ades, DNP, FNP-BC, AOCN: Director, Cancer Information, American Cancer Society
  • Carlos Alvarado, MD: Emeritus Professor, Emory University
  • John D. Bergsagel, MD, Oncologist at Children’s Healthcare of Atlanta at Scottish Rite and Assistant Professor of Pediatrics, Department of Pediatrics, Emory University School of Medicine
  • Leon Bernal-Mizrachi, MD: Assistant Professor of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
  • William H. Chambers, PhD: Director, Clinical Cancer Research and Immunology, American Cancer Society
  • Harry Findley, PhD: Emeritus Professor, Emory University
  • Howard Katzenstein, MD: Medical Director, Pediatric Hematology Oncology, Vanderbilt University School of Medicine
  • Erwin G. Van Meir, PhD: Professor, Departments of Neurosurgery and Hematology & Medical Oncology; Leader, Winship Cancer Institute Cancer Cell Biology Program; Founding Director, Graduate Program in Cancer Biology; and Director, Laboratory for Molecular Neuro-Oncology, Emory University School of Medicine
  • Edmund “Ned” K. Waller, MD, PhD, FAC: Professor of Medicine and Oncology, and Director, Bone Marrow and Stem Cell Transplant Center, Winship Cancer Institute of Emory University
  • Richard J. Woodcock, MD: Neuroradiologist, MRI & Imaging of Georgia

.

  • Screen Shot 2016-03-28 at 4.27.53 PM

    THE CURE STORE

    Be a walking advocate for children with cancer. Purchase CURE shirts, vests, hats and more from the CURE Store, where 100% of proceeds benefit CURE. Plus, you never know who you’ll strike up a conversation with while sporting your CURE gear. Click here to shop.

  • Screen Shot 2016-02-24 at 3.15.33 PM

    LAUREN’S RUN RACE RESULTS

    Thank you for attending the 22nd Annual Lauren’s Run 10k/5k/2k/Tot Trot and CURE Annual Picnic on April 24th at Concourse Office Park in Atlanta, GA. With your help, we had more than 2000 runners and raised more than $145,000 for pediatric cancer research. Please click here to check the race results.